New key regulator of acquisition of immune tolerance to tumor cells in cancer patients
Credit: Javier RodrÃguez-Ubreva Researchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona have identified a distinctive epigenetic event...







